Blog Archives
Search Blog Archives
Category Archives: BioTech/Pharma
Disease-causing agents – a potential source of medicine?
We can learn a lot from the world of parasites, which in general also includes bacteria, viruses and fungi. The medical profession has long focused on bacteria and viruses more-so than parasitic protozoa partly due to the fact of how … Continue reading
Posted in BioTech/Pharma, Business
Tagged Ancylostoma duodenale. Necator americanus, blood thinner, Corvas International, herpes virus, hookworm, HSV, inflammation, Louisiana State University School of Veterinary Medicine, MediGene, Myxoma virus, oncolytic viruses, parasites, protozoa, storke, Viron Therapeutics, VT-111
8 Comments
Helping the poorest of the poor fight disease
Imagine living day to day in a place plagued by constant poverty and unimaginable disease. AIDS, African trypanosomiasis (sleeping sickness), dracunculiasis (guinea worm disease), malaria, nodding syndrome, and onchocerciasis (river blindness) are some of the most common diseases the people … Continue reading
Posted in BioTech/Pharma, Business
Tagged African trypanosomiasis, AIDS, Ascaris lumbricoides, dracunculiasis, Ebola, Eflornithine, guinea worm disease, hookworm, malaria, Melarsoprol, nodding syndrome, onchocerciasis, parasites, Pentamidine, river blindness, roundworm, sleeping sickness, Sudan, Suramin, The Bill and Melinda Gates Foundation, The Carter Center, Trypanosoma brucei, trypanosome, whipworm
1 Comment
Pharmacogenetics – The future of “Personalized Medicine”
European Americans are ten to forty times more likely than African Americans to get a very aggressive type of skin cancer called Melanoma. People of Asian descent are more likely to have the inability to process alcohol efficiently – exposing … Continue reading
Posted in BioTech/Pharma, Business
Tagged BiDil, Biotech, NitroMed, Personalized Medicine, Pharma, Pharmaceuticals, Pharmacogenetics, Targeted Medicine
Leave a comment
Pharma Mega-Mergers: When you can’t innovate, merge
In April of 2009, Pfizer agreed to buyout Wyeth for $68 billion; Pfizer’s market cap at that time was just around $100 billion. The following month Merck trumped the Pfizer deal with a $41 billion merger with Schering-Plough. What was … Continue reading
Posted in BioTech/Pharma, Business
Tagged Biotech, Cozaar, Genentech, Lipitor, Mega-Mergers, Merck, Pfizer, Pharma, Pharmaceuticial, Roche, Schering-Plough, Singulair, Wall Street
Leave a comment